Effectiveness of Netarsudil as an Additional Therapy for Glaucoma in Patients Already on Maximally Tolerated Medical Therapy
Natacha C Villegas, Wen-Shin Lee Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USACorrespondence: Natacha C VillegasDepartment of Ophthalmology, Stanford University, Medical Center, 2452 Watson Court, Palo Alto, CA, 94303-5353, USATel +1 832 477-3498Email natacha...
Guardado en:
Autores principales: | Villegas NC, Lee WS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3cbfed0c33da4bf6a7fda5d577a9e67a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
por: Dasso L, et al.
Publicado: (2018) -
Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
por: Lerner SF, et al.
Publicado: (2019) -
Topical Medication Therapy for Glaucoma and Ocular Hypertension
por: Tao Wang, et al.
Publicado: (2021) -
Glaucoma therapy: preservative-free for all?
por: Thygesen J
Publicado: (2018) -
Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
por: Muñoz Negrete FJ, et al.
Publicado: (2017)